These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8730461)

  • 1. Acute effect of erythropoietin on endothelin release in uremia.
    Nurol A; Bahattin A; Tolga K; Tekin A; Abdülkerim B
    Nephron; 1996; 72(4):728-9. PubMed ID: 8730461
    [No Abstract]   [Full Text] [Related]  

  • 2. Uraemic pericarditis: a reversible inflammatory state of resistance to recombinant human erythropoietin in haemodialysis patients.
    Tarng DC; Huang TP
    Nephrol Dial Transplant; 1997 May; 12(5):1051-4. PubMed ID: 9175071
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin.
    Haberl M
    Aust Nurses J; 1990 Sep; 20(2):29. PubMed ID: 2268202
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible relation between restless legs and anaemia in renal dialysis patients.
    Roger SD; Harris DC; Stewart JH
    Lancet; 1991 Jun; 337(8756):1551. PubMed ID: 1675404
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of erythropoietin administration in uremia.
    Gurland HJ; Samtleben W; Schmidt B
    Contrib Nephrol; 1989; 70():172-7. PubMed ID: 2670428
    [No Abstract]   [Full Text] [Related]  

  • 7. Does erythropoietin cause epilepsy.
    Cengiz K; Işlek I
    Nephron; 1996; 73(2):320-1. PubMed ID: 8773367
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of recombinant human erythropoietin (rh-EPO) in the treatment of anemia in hemodialysis patients: a multicenter Italian experience.
    Buccianti G; Colombi L; Battistel V
    Haematologica; 1993; 78(2):111-7. PubMed ID: 8349186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to recombinant human erythropoietin (r-Hu EPO) and L-carnitine combination in patients with anemia of end-stage renal disease.
    Boran M; Dalva I; Gönenç F; Cetin S
    Nephron; 1996; 73(2):314-5. PubMed ID: 8773364
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of erythropoietin treatment on endocrine abnormalities in haemodialyzed patients.
    Kokot F; Wiecek A; Grzeszczak W; Klepacka J; Klin M; Lao M
    Contrib Nephrol; 1989; 76():257-70; discussion 270-2. PubMed ID: 2582782
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of correcting anemia with recombinant erythropoietin on the central hemodynamic indices of patients on regular hemodialysis].
    Ermolenko VM; Khvoĭnitskiĭ VA; Suprun EK; Tsukerman LI; Pokrovskiĭ IuA
    Ter Arkh; 1992; 64(7):86-8. PubMed ID: 1440377
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of erythropoietin administration on thyroid functions of the patients undergoing regular hemodialysis.
    Seyrek N; Paydas S; Sagliker Y
    Nephron; 1996; 72(4):714-5. PubMed ID: 8730452
    [No Abstract]   [Full Text] [Related]  

  • 13. [A multicenter trial of Recormon within the framework of international controlled research].
    Tareeva IE; Nikolaev AIu; Klepikov PV; Lashutin SV; Riabov SI; Shostka GD; Ermolenko VM; Rozental' RL; Vorob'ev PA; Miagkov AV
    Ter Arkh; 1992; 64(8):59-62. PubMed ID: 1440400
    [No Abstract]   [Full Text] [Related]  

  • 14. Correction of anaemia with recombinant human erythropoietin.
    Ponticelli C; Casati S
    Nephron; 1989; 52(3):201-8. PubMed ID: 2662045
    [No Abstract]   [Full Text] [Related]  

  • 15. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
    Fujita Y; Inoue S; Horiguchi S; Kuki A
    Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical definition of the uremic syndrome and possible therapeutic implications.
    Vanholder R; Hsu C; Ringoir S
    Artif Organs; 1993 Apr; 17(4):234-9. PubMed ID: 8498902
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemoglobin concentrations in chronic kidney disease.
    Steinbrook R
    Lancet; 2006 Dec; 368(9554):2191-3. PubMed ID: 17189015
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.
    Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A
    Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
    Romero González R; Torquet Escuder P
    Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant human erythropoietin and haemodialyser re-use.
    Dos Santos JP; Prata MM; Sousa FT; Barbas JV
    Nephron; 1990; 56(4):447-8. PubMed ID: 2080010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.